ABCG2 and malignant colon neoplasm: Therefore, in this manuscript, experiments are conducted to determine the reversal mechanism of VKNG-1 in anticancer drug resistance in vitro and in a tumor xenograft model in drug-resistant ABCG2-overexpressing colon cancers.